CA2247329C - Compositions contenant un agent antitumoral
- Google Patents
Compositions contenant un agent antitumoral
Download PDF
Info
Publication number
CA2247329C
CA2247329CCA002247329ACA2247329ACA2247329CCA 2247329 CCA2247329 CCA 2247329CCA 002247329 ACA002247329 ACA 002247329ACA 2247329 ACA2247329 ACA 2247329ACA 2247329 CCA2247329 CCA 2247329C
Authority
CA
Canada
Prior art keywords
composition
indol
chloro
sulfamoylbenzenesulfonamide
basic substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co LtdfiledCriticalEisai Co Ltd
Priority claimed from PCT/JP1997/000560external-prioritypatent/WO1997030706A1/fr
Publication of CA2247329A1publicationCriticalpatent/CA2247329A1/fr
Application grantedgrantedCritical
Publication of CA2247329CpublicationCriticalpatent/CA2247329C/fr
L'invention a trait à une solution à administration parentérale comportant un agent antitumoral peu soluble dans l'eau, une composition, en l'occurrence, contenant N-(3-chloro-1H-indol-7-yl)-4-sulfamoylbenzènesulfonamide ainsi qu'une substance de base et dont le pH en solution est égal ou supérieur à 7.
CA002247329A1996-02-261997-02-26Compositions contenant un agent antitumoral
Expired - Fee RelatedCA2247329C
(fr)
Spôsob prípravy kryštalickej formy 3/2 hydrátu 7-[(7-(S)- amino-5-azaspiro[2.4]-heptan-5-yl]-8-chlór-6-flór-1-[(1R,2S)-2- flórcyklopropyl]-4-oxo-1,4-dihydrochinolín-3-karboxylovej kyseliny